Regulation	O
of	O
GM-CSF	B-DNA
gene	I-DNA
transcription	O
by	O
core-binding	B-protein
factor	I-protein
.	O

GM-CSF	B-DNA
gene	I-DNA
activation	O
in	O
T	B-cell_type
cells	I-cell_type
is	O
known	O
to	O
involve	O
the	O
transcription	B-protein
factors	I-protein
nuclear	B-protein
factor-kappa	I-protein
B	I-protein
,	O
AP-1	B-protein
,	O
NFAT	B-protein
,	O
and	O
Sp1	O
.	O

Here	O
we	O
demonstrate	O
that	O
the	O
human	B-DNA
GM-CSF	I-DNA
promoter	I-DNA
and	I-DNA
enhancer	I-DNA
also	O
encompass	O
binding	O
sites	O
for	O
core-binding	B-protein
factor	I-protein
(	O
CBF	B-protein
)	O
.	O

Significantly	O
,	O
the	O
CBF	B-DNA
sites	I-DNA
are	O
in	O
each	O
case	O
contained	O
within	O
the	O
minimum	O
essential	B-DNA
core	I-DNA
regions	I-DNA
required	O
for	O
inducible	O
activation	O
of	O
transcription	O
.	O

Furthermore	O
,	O
these	O
core	O
regions	O
of	O
the	O
enhancer	O
and	O
promoter	O
each	O
encompass	O
closely	B-DNA
linked	I-DNA
binding	I-DNA
sites	I-DNA
for	O
CBF	B-protein
,	O
AP-1	B-protein
,	O
and	O
NFATp	B-protein
.	O

The	O
GM-CSF	B-DNA
promoter	I-DNA
CBF	I-DNA
site	I-DNA
TGTGGTCA	O
is	O
located	O
51	B-DNA
bp	I-DNA
upstream	I-DNA
of	O
the	O
transcription	B-DNA
start	I-DNA
site	I-DNA
and	O
also	O
overlaps	O
a	O
YY-1	B-DNA
binding	I-DNA
site	I-DNA
.	O

A	O
2-bp	B-DNA
mutation	I-DNA
within	O
the	O
CBF	B-protein
site	O
resulted	O
in	O
a	O
2-3-fold	O
decrease	O
in	O
the	O
activities	O
of	O
both	O
a	O
69-bp	B-DNA
proximal	I-DNA
promoter	I-DNA
fragment	I-DNA
and	O
a	O
627-bp	B-DNA
full-length	I-DNA
promoter	I-DNA
fragment	I-DNA
.	O

Stepwise	O
deletions	O
into	O
the	O
proximal	B-DNA
promoter	I-DNA
also	O
revealed	O
that	O
the	O
CBF	B-protein
site	O
,	O
but	O
not	O
the	O
YY-1	B-DNA
site	I-DNA
,	O
was	O
required	O
for	O
efficient	O
induction	O
of	O
transcriptional	O
activation	O
.	O

The	O
AML1	B-DNA
and	I-DNA
CBF	I-DNA
beta	I-DNA
genes	I-DNA
that	O
encode	O
CBF	B-protein
each	O
have	O
the	O
ability	O
to	O
influence	O
cell	O
growth	O
and	O
differentiation	O
and	O
have	O
been	O
implicated	O
as	O
proto-oncogenes	B-DNA
in	O
acute	O
myeloid	O
leukemia	O
.	O

This	O
study	O
adds	O
GM-CSF	B-protein
to	O
a	O
growing	O
list	O
of	O
cytokines	B-protein
and	O
receptors	O
that	O
are	O
regulated	O
by	O
CBF	B-protein
and	O
which	O
control	O
the	O
growth	O
,	O
differentiation	O
,	O
and	O
activation	O
of	O
hemopoietic	B-cell_type
cells	I-cell_type
.	O

The	O
GM-CSF	B-DNA
locus	I-DNA
may	O
represent	O
one	O
of	O
several	O
target	O
genes	B-protein
that	O
are	O
dysregulated	O
in	O
acute	O
myeloid	O
leukemia	O
.	O

Vol	NULL
.	NULL

7	NULL
,	NULL
917-922	NULL
,	NULL
July	NULL
1996	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Regulation	NULL
of	NULL
GM-CSF	NULL
Gene	NULL
Transcription	NULL
by	NULL
Core-binding	NULL
Factor	NULL
'	NULL
Peter	NULL
N.	NULL
Cockerill	NULL
,	NULL
*	NULL
Cameron	NULL
S.	NULL
Osborne	NULL
,	NULL
Andrew	NULL
G.	NULL
Bert	NULL
,	NULL
and	NULL
Rina	NULL
J.	NULL
M.	NULL
Grotto	NULL
Division	NULL
of	NULL
Human	NULL
Immunology	NULL
,	NULL
Hanson	NULL
Centre	NULL
For	NULL
Cancer	NULL
Research	NULL
,	NULL
Institute	NULL
for	NULL
Medical	NULL
and	NULL
Veterinary	NULL
Science	NULL
,	NULL
Frome	NULL
Road	NULL
,	NULL
Adelaide	NULL
5000	NULL
,	NULL
Australia	NULL
Abstract	NULL
GM-CSF	NULL
gene	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
known	NULL
to	NULL
involve	NULL
the	NULL
transcription	NULL
factors	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
Sp1	NULL
.	NULL

Here	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
human	NULL
GM-CSF	NULL
promoter	NULL
and	NULL
enhancer	NULL
also	NULL
encompass	NULL
binding	NULL
sites	NULL
for	NULL
core-binding	NULL
factor	NULL
(	NULL
CBF	NULL
)	NULL
.	NULL

Significantly	NULL
,	NULL
the	NULL
CBF	NULL
sites	NULL
are	NULL
in	NULL
each	NULL
case	NULL
contained	NULL
within	NULL
the	NULL
minimum	NULL
essential	NULL
core	NULL
regions	NULL
required	NULL
for	NULL
inducible	NULL
activation	NULL
of	NULL
transcription	NULL
.	NULL

Furthermore	NULL
,	NULL
these	NULL
core	NULL
regions	NULL
of	NULL
the	NULL
enhancer	NULL
and	NULL
promoter	NULL
each	NULL
encompass	NULL
closely	NULL
linked	NULL
binding	NULL
sites	NULL
for	NULL
CBF	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NFATp	NULL
.	NULL

The	NULL
GM-CSF	NULL
promoter	NULL
CBF	NULL
site	NULL
TGTGGTCA	NULL
is	NULL
located	NULL
51	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
and	NULL
also	NULL
overlaps	NULL
a	NULL
YY-1	NULL
binding	NULL
site	NULL
.	NULL

A	NULL
2-bp	NULL
mutation	NULL
within	NULL
the	NULL
CBF	NULL
site	NULL
resulted	NULL
in	NULL
a	NULL
2-3-fold	NULL
decrease	NULL
in	NULL
the	NULL
activities	NULL
of	NULL
both	NULL
a	NULL
69-bp	NULL
proximal	NULL
promoter	NULL
fragment	NULL
and	NULL
a	NULL
627-bp	NULL
full-length	NULL
promoter	NULL
fragment	NULL
.	NULL

Stepwise	NULL
deletions	NULL
into	NULL
the	NULL
proximal	NULL
promoter	NULL
also	NULL
revealed	NULL
that	NULL
the	NULL
CBF	NULL
site	NULL
,	NULL
but	NULL
not	NULL
the	NULL
YY-1	NULL
site	NULL
,	NULL
was	NULL
required	NULL
for	NULL
efficient	NULL
induction	NULL
of	NULL
transcriptional	NULL
activation	NULL
.	NULL

The	NULL
AML1	NULL
and	NULL
CBFB	NULL
genes	NULL
that	NULL
encode	NULL
CBF	NULL
each	NULL
have	NULL
the	NULL
ability	NULL
to	NULL
influence	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
and	NULL
have	NULL
been	NULL
implicated	NULL
as	NULL
proto-oncogenes	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

This	NULL
study	NULL
adds	NULL
GM-CSF	NULL
to	NULL
a	NULL
growing	NULL
list	NULL
of	NULL
cytokines	NULL
and	NULL
receptors	NULL
that	NULL
are	NULL
regulated	NULL
by	NULL
CBF	NULL
and	NULL
which	NULL
control	NULL
the	NULL
growth	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
activation	NULL
of	NULL
hemopoietic	NULL
cells	NULL
.	NULL

The	NULL
GM-CSF	NULL
locus	NULL
may	NULL
represent	NULL
one	NULL
of	NULL
several	NULL
target	NULL
genes	NULL
that	NULL
are	NULL
dysregulated	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

Introduction	NULL
GM-CSF	NULL
is	NULL
a	NULL
cytokine	NULL
that	NULL
regulates	NULL
the	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
function	NULL
of	NULL
cells	NULL
of	NULL
the	NULL
granulocyte	NULL
,	NULL
macro	NULL
Received	NULL
1/2/96	NULL
;	NULL
revised	NULL
4/23/96	NULL
;	NULL
accepted	NULL
4/26/96	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
National	NULL
Health	NULL
and	NULL
Medical	NULL
Research	NULL
Council	NULL
{	NULL
Australia	NULL
)	NULL
.	NULL

2	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Phone	NULL
:	NULL
61	NULL
8	NULL
222	NULL
3297	NULL
;	NULL
Fax	NULL
:	NULL
61	NULL
8	NULL
232	NULL
4092	NULL
;	NULL
E-mail	NULL
:	NULL
peockeri	NULL
@	NULL
immuno.imys.sa.gov.au	NULL
.	NULL

®	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
GM-CSF	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
AML	NULL
,	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
;	NULL
TCR	NULL
,	NULL
T	NULL
cell	NULL
receptor	NULL
;	NULL
CBF	NULL
,	NULL
core-binding	NULL
factor	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
.	NULL

phage	NULL
,	NULL
and	NULL
eosinophil	NULL
lineages	NULL
(	NULL
1	NULL
)	NULL
.	NULL

GM-CSF	NULL
is	NULL
induced	NULL
in	NULL
T	NULL
celis	NULL
by	NULL
TCR	NULL
stimulation	NULL
and	NULL
in	NULL
myeloid	NULL
cells	NULL
,	NULL
endothelial	NULL
cells	NULL
,	NULL
and	NULL
fibroblasts	NULL
by	NULL
pro-inflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
IL-1	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

GM-CSF	NULL
is	NULL
also	NULL
produced	NULL
either	NULL
constitutively	NULL
or	NULL
in	NULL
response	NULL
to	NULL
agents	NULL
such	NULL
as	NULL
IL-1	NULL
in	NULL
a	NULL
high	NULL
proportion	NULL
of	NULL
AMLs	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Although	NULL
GM-CSF	NULL
acts	NULL
as	NULL
a	NULL
growth	NULL
factor	NULL
for	NULL
some	NULL
AMLs	NULL
,	NULL
in	NULL
other	NULL
cases	NULL
it	NULL
may	NULL
lead	NULL
to	NULL
differentiation	NULL
and	NULL
extinction	NULL
of	NULL
leukemic	NULL
cells	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

The	NULL
human	NULL
GM-CSF	NULL
locus	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
promoter	NULL
(	NULL
6-8	NULL
)	NULL
and	NULL
an	NULL
upstream	NULL
enhancer	NULL
(	NULL
9-11	NULL
)	NULL
that	NULL
both	NULL
respond	NULL
to	NULL
TCR	NULL
signals	NULL
.	NULL

These	NULL
signals	NULL
induce	NULL
highly	NULL
cooperative	NULL
binding	NULL
of	NULL
NFATp/c	NULL
and	NULL
AP-1	NULL
to	NULL
several	NULL
sites	NULL
in	NULL
the	NULL
enhancer	NULL
and	NULL
moderate	NULL
binding	NULL
of	NULL
these	NULL
factors	NULL
to	NULL
overlapping	NULL
sites	NULL
in	NULL
the	NULL
proximal	NULL
region	NULL
(	NULL
-33	NULL
to	NULL
-47	NULL
)	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

The	NULL
distal	NULL
region	NULL
of	NULL
the	NULL
promoter	NULL
(	NULL
-70	NULL
to	NULL
~-103	NULL
)	NULL
associates	NULL
with	NULL
members	NULL
of	NULL
the	NULL
nuclear	NULL
factor-	NULL
«	NULL
B/Rel	NULL
(	NULL
7	NULL
,	NULL
12	NULL
)	NULL
and	NULL
Sp1	NULL
(	NULL
13	NULL
)	NULL
families	NULL
of	NULL
transcriptional	NULL
activators	NULL
.	NULL

Although	NULL
the	NULL
intervening	NULL
segment	NULL
of	NULL
the	NULL
promoter	NULL
(	NULL
-48	NULL
to	NULL
-69	NULL
)	NULL
is	NULL
activated	NULL
by	NULL
additional	NULL
unknown	NULL
factors	NULL
(	NULL
14-16	NULL
)	NULL
,	NULL
it	NULL
can	NULL
also	NULL
be	NULL
repressed	NULL
by	NULL
the	NULL
transcription	NULL
factor	NULL
YY-1	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
highly	NULL
conserved	NULL
region	NULL
of	NULL
the	NULL
promoter	NULL
extends	NULL
116	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
and	NULL
is	NULL
sufficient	NULL
to	NULL
support	NULL
maximum	NULL
promoter	NULL
activity	NULL
.	NULL

*	NULL
We	NULL
sought	NULL
additional	NULL
transcription	NULL
factors	NULL
that	NULL
may	NULL
either	NULL
determine	NULL
the	NULL
cell	NULL
specificity	NULL
of	NULL
GM-CSF	NULL
expression	NULL
or	NULL
be	NULL
involved	NULL
in	NULL
dysregulated	NULL
GM-CSF	NULL
expression	NULL
in	NULL
AML	NULL
.	NULL

CBF	NULL
is	NULL
one	NULL
such	NULL
factor	NULL
that	NULL
required	NULL
investigation	NULL
because	NULL
it	NULL
functions	NULL
in	NULL
cell	NULL
types	NULL
that	NULL
express	NULL
GM-CSF	NULL
(	NULL
17-19	NULL
)	NULL
and	NULL
its	NULL
genes	NULL
are	NULL
frequently	NULL
disrupted	NULL
in	NULL
AML	NULL
(	NULL
20-22	NULL
)	NULL
.	NULL

CBF	NULL
is	NULL
constitutively	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
myeloid	NULL
cells	NULL
and	NULL
binds	NULL
to	NULL
DNA	NULL
as	NULL
a	NULL
complex	NULL
of	NULL
two	NULL
proteins	NULL
,	NULL
CBFa	NULL
and	NULL
CBFB	NULL
.	NULL

Genes	NULL
known	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
CBF	NULL
include	NULL
cytokines	NULL
and	NULL
receptors	NULL
such	NULL
as	NULL
IL-3	NULL
,	NULL
the	NULL
TCR	NULL
,	NULL
and	NULL
the	NULL
CSF-1	NULL
receptor	NULL
(	NULL
17-19	NULL
)	NULL
.	NULL

In	NULL
retroviruses	NULL
,	NULL
CBF	NULL
motifs	NULL
are	NULL
determinants	NULL
of	NULL
T	NULL
cell	NULL
tropism	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
AML1	NULL
gene	NULL
,	NULL
which	NULL
encodes	NULL
CBFa	NULL
,	NULL
and	NULL
the	NULL
CBFB	NULL
gene	NULL
have	NULL
both	NULL
been	NULL
identified	NULL
as	NULL
common	NULL
chromosomal	NULL
translocation	NULL
breakpoints	NULL
in	NULL
AML	NULL
,	NULL
thus	NULL
implicating	NULL
them	NULL
as	NULL
a	NULL
proto-oncogenes	NULL
(	NULL
20-22	NULL
)	NULL
.	NULL

AML1	NULL
gene	NULL
translocations	NULL
convert	NULL
CBF	NULL
into	NULL
a	NULL
dominant	NULL
repressor	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

We	NULL
searched	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
and	NULL
enhancer	NULL
for	NULL
CBF-like	NULL
motifs	NULL
and	NULL
in	NULL
each	NULL
case	NULL
identified	NULL
CBF-binding	NULL
sites	NULL
in	NULL
essential	NULL
core	NULL
regions	NULL
.	NULL

These	NULL
findings	NULL
have	NULL
implications	NULL
regarding	NULL
the	NULL
role	NULL
of	NULL
CBF	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
in	NULL
AML	NULL
.	NULL

Results	NULL
The	NULL
GM-CSF	NULL
Proximal	NULL
Promoter	NULL
Encompasses	NULL
a	NULL
CBF	NULL
Binding	NULL
Site	NULL
.	NULL

To	NULL
search	NULL
for	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
that	NULL
might	NULL
regulate	NULL
GM-CSF	NULL
expression	NULL
in	NULL
both	NULL
T	NULL
cells	NULL
and	NULL
myeloid	NULL
cells	NULL
,	NULL
we	NULL
screened	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
for	NULL
CBF	NULL
*	NULL
P.	NULL
Cockerill	NULL
and	NULL
C.	NULL
Osbome	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

918	NULL
-	NULL
Regulation	NULL
of	NULL
the	NULL
GM-CSF	NULL
Gene	NULL
by	NULL
CBF	NULL
A	NULL
Spl	NULL
CBF	NULL
YY-1	NULL
AP-1/NFAT	NULL
TATA	NULL
SacI	NULL
-69	NULL
-55	NULL
-47	NULL
Start	NULL
-~17	NULL
SalI	NULL
HindIII	NULL
TTTTGCCAGTGAGCCCAGTACACAGAGAGAAAGGCTAAAGTTCTgtcgacaagctt	NULL
-16	NULL
-1	NULL
B	NULL
+28	NULL
GM69	NULL
cCCCTGSGCATTTTGTGGTCACCATTAATCATTTCCTCTGTGTATTTAAGAGCT	NULL
GM6EIACBF	NULL
-	NULL
eCCCTGGCATTTTGTecTCACCATTAATCATTTCCTCTGTGTATTTAAGAGCT	NULL
GM47	NULL
cTTAATCATTTCCTCTGTGTATTTAAGAGCT	NULL
GM47CBF-E	NULL
-	NULL
cGTGATGAGGTTTGTGGGCAGCTTAATCATTTCCTCTCGTGTATTTAAGAGCT	NULL
C	NULL
GM	NULL
gatcCCTCCCTGGCATTTTGTGGTCACCATTAATq	NULL
GGAGGGACCGTAAAACACCAGTGGTAATTAcctaq	NULL
GMACBF	NULL
gatcCCTCCCTGGCATTTTGTeccTCACCATTAATg	NULL
GGAGGGACCGTAAAACAggAGTGGTAATTAcctag	NULL
GME	NULL
gat	NULL
ccGTTTGGTGATGAGGTTTGTGGGCAGCCACgq	NULL
gCAAACCACTACTCCAAACACCCGTCGGTGcctag	NULL
GMEACBF	NULL
gatccGTTTGGTGATGAGGTTTGTccGCAGCCACg	NULL
gCaAAACCACTACTCCAAACAggCGTCGGTGect	NULL
ag	NULL
TCR	NULL
gatccTGCAATGCATGTGGTTTCCAACCGTTAATq	NULL
gACGTTACGTACACCAAAGGTTGGCAATTAcctaq	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

GM-CSF	NULL
promoter	NULL
sequences	NULL
and	NULL
oligonucleotides	NULL
used	NULL
in	NULL
plasmids	NULL
and	NULL
binding	NULL
assays	NULL
.	NULL

Native	NULL
GM-CSF	NULL
promoter	NULL
sequences	NULL
are	NULL
shown	NULL
in	NULL
uppercase	NULL
,	NULL
while	NULL
altered	NULL
bases	NULL
and	NULL
cloning	NULL
sites	NULL
are	NULL
shown	NULL
in	NULL
lowercase	NULL
.	NULL

Transcription	NULL
factor	NULL
binding	NULL
sites	NULL
are	NULL
either	NULL
underlined	NULL
or	NULL
shown	NULL
in	NULL
bold	NULL
typeface	NULL
.	NULL

A	NULL
,	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
GM-CSF	NULL
promoter	NULL
depicting	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
and	NULL
positions	NULL
in	NULL
the	NULL
sequence	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
underlined	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
includes	NULL
the	NULL
segment	NULL
of	NULL
the	NULL
5	NULL
untranslated	NULL
region	NULL
and	NULL
downstream	NULL
cloning	NULL
sites	NULL
that	NULL
were	NULL
incorporated	NULL
into	NULL
each	NULL
plasmid	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

B	NULL
,	NULL
oligonucleotides	NULL
incorporated	NULL
into	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
plasmids	NULL
pGM69	NULL
,	NULL
pGM6IACBF	NULL
,	NULL
pGM47	NULL
,	NULL
and	NULL
pGMA47CBF-E.	NULL
C	NULL
,	NULL
GM-CSF	NULL
promoter	NULL
and	NULL
enhancer	NULL
and	NULL
TCR	NULL
CBF-binding	NULL
oligonucleotides	NULL
.	NULL

motifs	NULL
.	NULL

Within	NULL
the	NULL
vicinity	NULL
of	NULL
a	NULL
YY-1	NULL
binding	NULL
site	NULL
,	NULL
we	NULL
identified	NULL
the	NULL
sequence	NULL
TGTGGTCA	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
that	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
CBF	NULL
site	NULL
conserved	NULL
among	NULL
mammalian	NULL
type	NULL
C	NULL
retroviruses	NULL
(	NULL
24	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
properties	NULL
of	NULL
this	NULL
motif	NULL
in	NULL
gel	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
we	NULL
designed	NULL
a	NULL
probe	NULL
that	NULL
encompassed	NULL
the	NULL
YY-1	NULL
and	NULL
CBF	NULL
-like	NULL
sequences	NULL
but	NULL
not	NULL
the	NULL
downstream	NULL
AP-1	NULL
motif	NULL
or	NULL
the	NULL
upstream	NULL
Sp1	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
GM	NULL
)	NULL
.	NULL

For	NULL
a	NULL
control	NULL
,	NULL
we	NULL
used	NULL
the	NULL
well-characterized	NULL
TCR-5E3	NULL
CBF	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
TCR	NULL
;	NULL
Ref	NULL
.	NULL

17	NULL
)	NULL
.	NULL

The	NULL
GM-CSF	NULL
promoter	NULL
GM	NULL
probe	NULL
had	NULL
binding	NULL
properties	NULL
similar	NULL
to	NULL
the	NULL
TCR	NULL
CBF	NULL
probe	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
GM-CSF	NULL
probe	NULL
formed	NULL
specific	NULL
complexes	NULL
of	NULL
the	NULL
same	NULL
mobility	NULL
as	NULL
the	NULL
TCR	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
Lanes	NULL
1	NULL
and	NULL
8	NULL
)	NULL
.	NULL

The	NULL
GM	NULL
element	NULL
functioned	NULL
as	NULL
a	NULL
specific	NULL
competitor	NULL
of	NULL
CBF	NULL
binding	NULL
to	NULL
the	NULL
GM-CSF	NULL
and	NULL
TCR	NULL
probes	NULL
and	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
the	NULL
TCR	NULL
element	NULL
partially	NULL
suppressed	NULL
CBF	NULL
binding	NULL
to	NULL
the	NULL
GM-CSF	NULL
probe	NULL
.	NULL

The	NULL
GM-CSF	NULL
promoter	NULL
may	NULL
represent	NULL
a	NULL
relatively	NULL
high	NULL
affinity	NULL
CBF-binding	NULL
site	NULL
because	NULL
the	NULL
TCR	NULL
probe	NULL
was	NULL
a	NULL
less	NULL
effective	NULL
competitor	NULL
than	NULL
the	NULL
GM	NULL
probe	NULL
.	NULL

Complexes	NULL
formed	NULL
with	NULL
the	NULL
GM-CSF	NULL
probe	NULL
were	NULL
formally	NULL
identified	NULL
as	NULL
CBF	NULL
complexes	NULL
on	NULL
the	NULL
basis	NULL
that	NULL
they	NULL
were	NULL
eliminated	NULL
by	NULL
antisera	NULL
raised	NULL
against	NULL
either	NULL
the	NULL
CBFa	NULL
or	NULL
CBFB	NULL
components	NULL
of	NULL
CBF	NULL
but	NULL
not	NULL
by	NULL
an	NULL
unrelated	NULL
antisera	NULL
.	NULL

This	NULL
conclusion	NULL
was	NULL
further	NULL
supported	NULL
by	NULL
the	NULL
detection	NULL
of	NULL
faint	NULL
supershifted	NULL
bands	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
SF-	NULL
,	NULL
Lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
seen	NULL
with	NULL
both	NULL
CBF	NULL
antibodies	NULL
but	NULL
not	NULL
with	NULL
the	NULL
control	NULL
antibody	NULL
.	NULL

In	NULL
common	NULL
with	NULL
other	NULL
CBF	NULL
sites	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
,	NULL
the	NULL
central	NULL
GG	NULL
sequence	NULL
was	NULL
essential	NULL
for	NULL
binding	NULL
because	NULL
a	NULL
mutation	NULL
of	NULL
this	NULL
sequence	NULL
to	NULL
CC	NULL
eliminated	NULL
formation	NULL
of	NULL
CBF	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
GMACBF	NULL
;	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
Lane	NULL
12	NULL
)	NULL
.	NULL

The	NULL
GMACBF	NULL
oligonucleotide	NULL
also	NULL
lacked	NULL
the	NULL
ability	NULL
to	NULL
efficiently	NULL
inhibit	NULL
CBF	NULL
binding	NULL
to	NULL
either	NULL
the	NULL
GM-CSF	NULL
or	NULL
TCR	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
Lanes	NULL
3	NULL
and	NULL
10	NULL
)	NULL
.	NULL

Curiously	NULL
,	NULL
we	NULL
saw	NULL
no	NULL
evidence	NULL
of	NULL
YY-1	NULL
binding	NULL
to	NULL
the	NULL
GM-CSF	NULL
probe	NULL
as	NULL
the	NULL
only	NULL
other	NULL
complex	NULL
observed	NULL
was	NULL
a	NULL
nonspecific	NULL
one	NULL
.	NULL

The	NULL
GM-CSF	NULL
Enhancer	NULL
Core	NULL
Also	NULL
Encompasses	NULL
a	NULL
CBF	NULL
Binding	NULL
Site	NULL
.	NULL

Because	NULL
GM-CSF	NULL
gene	NULL
induction	NULL
involves	NULL
both	NULL
the	NULL
promoter	NULL
and	NULL
the	NULL
upstream	NULL
enhancer	NULL
,	NULL
we	NULL
screened	NULL
the	NULL
716-bp	NULL
enhancer	NULL
sequence	NULL
(	NULL
9	NULL
,	NULL
11	NULL
)	NULL
for	NULL
CBF-like	NULL
motifs	NULL
.	NULL

We	NULL
identified	NULL
the	NULL
CBF	NULL
-like	NULL
motif	NULL
TGTGGGCA	NULL
(	NULL
termed	NULL
here	NULL
as	NULL
the	NULL
GM450	NULL
element	NULL
)	NULL
just	NULL
downstream	NULL
from	NULL
the	NULL
GM420	NULL
NFAT	NULL
enhancer	NULL
element	NULL
and	NULL
within	NULL
the	NULL
previously	NULL
defined	NULL
inducible	NULL
DNase	NULL
!	NULL

hypersensitive	NULL
site	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

The	NULL
GM420	NULL
element	NULL
is	NULL
the	NULL
highest	NULL
affinity	NULL
NFATp/c-binding	NULL
sequence	NULL
in	NULL
the	NULL
enhancer	NULL
,	NULL
and	NULL
its	NULL
closely	NULL
linked	NULL
AP-1	NULL
and	NULL
NFAT	NULL
motifs	NULL
represent	NULL
the	NULL
only	NULL
functional	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
known	NULL
to	NULL
exist	NULL
within	NULL
the	NULL
160-bp	NULL
essential	NULL
core	NULL
region	NULL
(	NULL
10	NULL
)	NULL
.	NULL

It	NULL
is	NULL
highly	NULL
likely	NULL
that	NULL
at	NULL
least	NULL
one	NULL
other	NULL
transcription	NULL
factor	NULL
binding	NULL
site	NULL
resides	NULL
within	NULL
this	NULL
core	NULL
because	NULL
it	NULL
has	NULL
an	NULL
activity	NULL
similar	NULL
to	NULL
that	NULL
obtained	NULL
with	NULL
the	NULL
full-length	NULL
enhancer	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Significantly	NULL
,	NULL
the	NULL
CBF	NULL
-like	NULL
motif	NULL
also	NULL
lies	NULL
within	NULL
a	NULL
conserved	NULL
region	NULL
of	NULL
this	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
GM-CSF	NULL
probe	NULL
_	NULL
TCR	NULL
probe	NULL
&	NULL
U	NULL
M	NULL
j	NULL
j	NULL
o	NULL
$	NULL
3	NULL
3	NULL
fo	NULL
]	NULL
as	NULL
82aa	NULL
'	NULL
gy	NULL
8	NULL
5g	NULL
®	NULL
s	NULL
€	NULL
6	NULL
zgmﬁg	NULL
g	NULL
G	NULL
ﬁocgoo§ﬁwegﬁ	NULL
SF-	NULL
>	NULL
CBF-	NULL
>	NULL
me	NULL
-	NULL
wa	NULL
|	NULL
faf	NULL
@	NULL
loath	NULL
wom	NULL
tank	NULL
msd	NULL
lik	NULL
uss	NULL
lak	NULL
=	NULL
&	NULL
~	NULL
N	NULL
w-	NULL
y-	NULL
y	NULL
-	NULL
N	NULL
O	NULL
<	NULL
w	NULL
o	NULL
n	NULL
o	NULL
®	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Gel	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
of	NULL
Jurkat	NULL
T	NULL
cell	NULL
nuclear	NULL
extracts	NULL
with	NULL
GM-CSF	NULL
promoter	NULL
and	NULL
TCR	NULL
8E3	NULL
CBF-binding	NULL
oligonucleotides	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
antisera	NULL
give	NULL
rise	NULL
to	NULL
additional	NULL
nonspecific	NULL
bands	NULL
above	NULL
and	NULL
below	NULL
the	NULL
CBF	NULL
complex	NULL
in	NULL
Lanes	NULL
5-7	NULL
and	NULL
faint	NULL
supershifted	NULL
bands	NULL
(	NULL
SF	NULL
)	NULL
in	NULL
Lanes	NULL
5	NULL
and	NULL
6.	NULL
essential	NULL
core	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
and	NULL
is	NULL
within	NULL
a	NULL
region	NULL
that	NULL
is	NULL
protected	NULL
by	NULL
nuclear	NULL
factors	NULL
in	NULL
footprinting	NULL
studies	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
GM450	NULL
motif	NULL
was	NULL
identified	NULL
as	NULL
a	NULL
CBF-binding	NULL
site	NULL
by	NULL
the	NULL
same	NULL
criteria	NULL
used	NULL
to	NULL
define	NULL
the	NULL
CBF	NULL
site	NULL
in	NULL
the	NULL
promoter	NULL
{	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

An	NULL
oligonucleotide	NULL
probe	NULL
encompassing	NULL
the	NULL
GM4SO	NULL
motif	NULL
(	NULL
Figs	NULL
.	NULL

1C	NULL
,	NULL
GME	NULL
,	NULL
and	NULL
3	NULL
)	NULL
associated	NULL
with	NULL
a	NULL
CBF-like	NULL
factor	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
Lanes	NULL
1	NULL
and	NULL
8	NULL
)	NULL
that	NULL
was	NULL
specifically	NULL
supershifted	NULL
by	NULL
CBFa	NULL
and	NULL
8	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
SF-	NULL
,	NULL
Lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

The	NULL
CBF	NULL
complex	NULL
was	NULL
completely	NULL
blocked	NULL
by	NULL
either	NULL
the	NULL
TCR	NULL
competitor	NULL
or	NULL
excess	NULL
GME	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
Lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
but	NULL
was	NULL
only	NULL
partly	NULL
blocked	NULL
by	NULL
a	NULL
mutated	NULL
GME	NULL
competitor	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
Lane	NULL
7	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
GG	NULL
to	NULL
CC	NULL
mutation	NULL
within	NULL
the	NULL
GMEACBF	NULL
probe	NULL
was	NULL
sufficient	NULL
to	NULL
eliminate	NULL
CBF	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
Lane	NULL
9	NULL
)	NULL
.	NULL

By	NULL
comparison	NULL
with	NULL
the	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
the	NULL
GME	NULL
probe	NULL
appeared	NULL
to	NULL
be	NULL
a	NULL
weaker	NULL
CBF	NULL
binding	NULL
site	NULL
than	NULL
either	NULL
the	NULL
GM	NULL
or	NULL
the	NULL
TCR	NULL
probes	NULL
.	NULL

The	NULL
GM-CSF	NULL
enhancer	NULL
CBF	NULL
site	NULL
overlaps	NULL
the	NULL
sequence	NULL
TGAGGTTT	NULL
that	NULL
also	NULL
bears	NULL
some	NULL
resemblance	NULL
to	NULL
CBF	NULL
elements	NULL
,	NULL
but	NULL
this	NULL
sequence	NULL
was	NULL
unable	NULL
to	NULL
support	NULL
detectable	NULL
CBF	NULL
complex	NULL
formation	NULL
with	NULL
the	NULL
GMEACBF	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
Lane	NULL
9	NULL
)	NULL
.	NULL

This	NULL
sequence	NULL
may	NULL
,	NULL
however	NULL
,	NULL
function	NULL
as	NULL
a	NULL
very	NULL
weak	NULL
CBF	NULL
site	NULL
and	NULL
account	NULL
for	NULL
the	NULL
partial	NULL
competition	NULL
of	NULL
CBF	NULL
binding	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
Lane	NULL
7	NULL
.	NULL

GME	NULL
probe	NULL
P	NULL
é	NULL
'	NULL
g	NULL
g	NULL
a	NULL
5	NULL
“	NULL
685	NULL
LL	NULL
2288588	NULL
``	NULL
g	NULL
#	NULL
a	NULL
o	NULL
0	NULL
°	NULL
4	NULL
3	NULL
5B	NULL
Paws	NULL
3	NULL
=	NULL
®	NULL
M	NULL
§	NULL
0	NULL
c	NULL
UO	NULL
O	NULL
ol—	NULL
(	NULL
DC	NULL
'D	NULL
SF-	NULL
»	NULL
CBF-	NULL
>	NULL
w	NULL
m	NULL
[	NULL
=	NULL
]	NULL
was	NULL
whee	NULL
woul	NULL
ant	NULL
)	NULL
{	NULL
rea	NULL
~	NULL
N	NULL
O	NULL
<	NULL
4	NULL
w	NULL
©	NULL
hn	NULL
o	NULL
o	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

-	NULL
Get	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
of	NULL
Jurkat	NULL
T	NULL
cell	NULL
nuclear	NULL
extracts	NULL
with	NULL
GM-CSF	NULL
enhancer	NULL
and	NULL
TCR	NULL
CBF-binding	NULL
oligonucleotides	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
antisera	NULL
give	NULL
rise	NULL
to	NULL
additional	NULL
supershifted	NULL
bands	NULL
(	NULL
SF	NULL
)	NULL
in	NULL
Lanes	NULL
2	NULL
and	NULL
3	NULL
.	NULL

The	NULL
CBF	NULL
Sites	NULL
Support	NULL
Inducible	NULL
GM-CSF	NULL
Promoter	NULL
Function	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
function	NULL
of	NULL
the	NULL
CBF	NULL
site	NULL
in	NULL
the	NULL
promoter	NULL
,	NULL
we	NULL
prepared	NULL
luciferase	NULL
reporter	NULL
gene	NULL
plasmids	NULL
in	NULL
which	NULL
the	NULL
GM-CSF	NULL
proximal	NULL
promoter	NULL
was	NULL
truncated	NULL
either	NULL
immediately	NULL
after	NULL
the	NULL
AP-1	NULL
site	NULL
at	NULL
-47	NULL
(	NULL
GM47	NULL
)	NULL
,	NULL
at	NULL
the	NULL
BstEll	NULL
site	NULL
at	NULL
-55	NULL
(	NULL
GMS55	NULL
)	NULL
,	NULL
just	NULL
before	NULL
the	NULL
Sp1-like	NULL
motif	NULL
(	NULL
13	NULL
)	NULL
at	NULL
-69	NULL
(	NULL
GM69	NULL
)	NULL
,	NULL
or	NULL
at	NULL
-627	NULL
to	NULL
include	NULL
all	NULL
of	NULL
the	NULL
promoter	NULL
(	NULL
GM627	NULL
;	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
GM47	NULL
construct	NULL
has	NULL
a	NULL
truncated	NULL
YY-1	NULL
motif	NULL
,	NULL
whereas	NULL
the	NULL
GMSS5	NULL
construct	NULL
has	NULL
lost	NULL
the	NULL
ability	NULL
to	NULL
bind	NULL
CBF	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Each	NULL
GM-CSF	NULL
promoter/luciferase	NULL
reporter	NULL
gene	NULL
plasmid	NULL
was	NULL
transiently	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Because	NULL
GM-CSF	NULL
expression	NULL
is	NULL
highly	NULL
induc-ible	NULL
,	NULL
we	NULL
measured	NULL
luciferase	NULL
expression	NULL
in	NULL
transfected	NULL
cells	NULL
that	NULL
were	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
for	NULL
9	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
and	NULL
A23187	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
P//	NULL
)	NULL
.	NULL

This	NULL
combination	NULL
of	NULL
phorbol	NULL
ester	NULL
and	NULL
calcium	NULL
ionophore	NULL
mimics	NULL
signals	NULL
that	NULL
normally	NULL
originate	NULL
from	NULL
the	NULL
TCR	NULL
.	NULL

The	NULL
pGMA47	NULL
and	NULL
pGMSS	NULL
plasmids	NULL
,	NULL
which	NULL
encompass	NULL
the	NULL
AP-1	NULL
and	NULL
NFAT	NULL
sites	NULL
but	NULL
not	NULL
the	NULL
CBF	NULL
motif	NULL
,	NULL
were	NULL
very	NULL
poorly	NULL
induced	NULL
,	NULL
and	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
YY-1-like	NULL
motif	NULL
had	NULL
no	NULL
influence	NULL
upon	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
inclusion	NULL
of	NULL
the	NULL
CBF	NULL
site	NULL
increased	NULL
the	NULL
inducible	NULL
activity	NULL
of	NULL
the	NULL
proximal	NULL
promoter	NULL
2-fold	NULL
while	NULL
having	NULL
little	NULL
effect	NULL
on	NULL
its	NULL
constitutive	NULL
activity	NULL
920	NULL
-	NULL
Regulation	NULL
of	NULL
the	NULL
GM-CSF	NULL
Gene	NULL
by	NULL
CBF	NULL
GM47	NULL
a1	NULL
Ar-	NULL
[	NULL
NFAT	NULL
GMSS	NULL
188	NULL
-_-	NULL
faz	NULL
)	NULL
GM69	NULL
-69	NULL
FATp/d	NULL
Lay	NULL
-e	NULL
GM6IACBF	NULL
69	NULL
f	NULL
d-	NULL
]	NULL
TATA	NULL
pet	NULL
i	NULL
{	NULL
rara	NULL
}	NULL
ame	NULL
?	NULL

s	NULL
-	NULL
#	NULL
£2	NULL
}	NULL
,	NULL
GMeéez7ACBF	NULL
+-	NULL
[	NULL
se	NULL
]	NULL
r-	NULL
i	NULL
ame	NULL
?	NULL

car-e	NULL
Enhancer	NULL
core	NULL
-f	NULL
®	NULL
W	NULL
17	NULL
_L	NULL
0.93	NULL
2083	NULL
6	NULL
o	NULL
S	NULL
30.7—	NULL
{	NULL
]	NULL
pA	NULL
gos	NULL
£0.57	NULL
8	NULL
~	NULL
1	NULL
40.43	NULL
a	NULL
3	NULL
>	NULL
8034	NULL
®	NULL
``	NULL
*	NULL
0.2	NULL
0.14	NULL
GM4t	NULL
_	NULL
GMSss_	NULL
GM6	NULL
$	NULL
-	NULL
GMs	NULL
)	NULL
_	NULL
GM47	NULL
-	NULL
GMée2	NULL
-	NULL
GMe	NULL
ACBF	NULL
_	NULL
CBF-E	NULL
ACBF	NULL
n=8	NULL
n=l	NULL
6	NULL
n=l	NULL
8	NULL
n=14	NULL
n=8	NULL
n=24	NULL
11:8	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Transient	NULL
transfection	NULL
assays	NULL
of	NULL
GM-CSF	NULL
promoter/luciferase	NULL
reporter	NULL
gene	NULL
plasmids	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Several	NULL
transfections	NULL
were	NULL
performed	NULL
on	NULL
each	NULL
of	NULL
two	NULL
independent	NULL
clones	NULL
of	NULL
each	NULL
plasmid	NULL
,	NULL
with	NULL
the	NULL
total	NULL
number	NULL
of	NULL
assays	NULL
indicated	NULL
by	NULL
n.	NULL
Twenty-four	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
9	NULL
h	NULL
with	NULL
PMA	NULL
and	NULL
A23187	NULL
(	NULL
P/	NULL
)	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
harvested	NULL
for	NULL
luciferase	NULL
assay	NULL
.	NULL

[	NULL
]	NULL
,	NULL
the	NULL
mean	NULL
of	NULL
at	NULL
least	NULL
eight	NULL
transfections	NULL
,	NULL
and	NULL
the	NULL
data	NULL
are	NULL
expressed	NULL
relative	NULL
to	NULL
pGM627	NULL
;	NULL
bars	NULL
,	NULL
SE	NULL
.	NULL

I	NULL
,	NULL
the	NULL
mean	NULL
of	NULL
at	NULL
least	NULL
four	NULL
unstimulated	NULL
control	NULL
transfections	NULL
;	NULL
bars	NULL
,	NULL
SE	NULL
.	NULL

(	NULL
pGM69	NULL
;	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

This	NULL
69-bp	NULL
proximal	NULL
region	NULL
of	NULL
the	NULL
promoter	NULL
was	NULL
sufficient	NULL
to	NULL
support	NULL
a	NULL
level	NULL
of	NULL
activity	NULL
one-third	NULL
of	NULL
that	NULL
obtained	NULL
with	NULL
the	NULL
-627	NULL
fragment	NULL
that	NULL
encompasses	NULL
the	NULL
full-length	NULL
promoter	NULL
(	NULL
pGM627	NULL
)	NULL
.	NULL

The	NULL
pGM69	NULL
plasmid	NULL
relied	NULL
on	NULL
an	NULL
intact	NULL
CBF	NULL
binding	NULL
site	NULL
for	NULL
its	NULL
increased	NULL
level	NULL
of	NULL
inducible	NULL
activity	NULL
as	NULL
a	NULL
2-bp	NULL
mutation	NULL
within	NULL
the	NULL
CBF	NULL
site	NULL
reduced	NULL
promoter	NULL
activity	NULL
by	NULL
3-fold	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
GM6IACBF	NULL
)	NULL
.	NULL

The	NULL
GM6IACBF	NULL
plasmid	NULL
carries	NULL
the	NULL
same	NULL
2-bp	NULL
mutation	NULL
as	NULL
that	NULL
present	NULL
in	NULL
the	NULL
GMACBF	NULL
probe	NULL
that	NULL
was	NULL
sufficient	NULL
to	NULL
abolish	NULL
CBF	NULL
binding	NULL
.	NULL

The	NULL
CBF	NULL
site	NULL
was	NULL
also	NULL
required	NULL
for	NULL
efficient	NULL
activation	NULL
of	NULL
the	NULL
full-length	NULL
promoter	NULL
as	NULL
the	NULL
same	NULL
CBF	NULL
site	NULL
mutation	NULL
introduced	NULL
into	NULL
the	NULL
pGM627	NULL
plasmid	NULL
resulted	NULL
in	NULL
a	NULL
2-3-fold	NULL
decrease	NULL
in	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
GM627ACBF	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
promoter	NULL
CBF	NULL
site	NULL
,	NULL
the	NULL
GM-CSF	NULL
enhancer	NULL
GM450	NULL
CBF	NULL
binding	NULL
site	NULL
also	NULL
sits	NULL
in	NULL
close	NULL
proximity	NULL
to	NULL
AP-1	NULL
and	NULL
NFATp/c	NULL
motifs	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

With	NULL
the	NULL
exception	NULL
of	NULL
the	NULL
non-functional	NULL
GM400	NULL
AP-1	NULL
motif	NULL
,	NULL
these	NULL
three	NULL
closely	NULL
linked	NULL
motifs	NULL
are	NULL
the	NULL
only	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
known	NULL
to	NULL
exist	NULL
within	NULL
the	NULL
160-bp	NULL
enhancer	NULL
core	NULL
(	NULL
10	NULL
)	NULL
.	NULL

We	NULL
,	NULL
therefore	NULL
,	NULL
assessed	NULL
the	NULL
function	NULL
of	NULL
the	NULL
GM4SO	NULL
motif	NULL
by	NULL
linking	NULL
it	NULL
directly	NULL
upstream	NULL
of	NULL
the	NULL
AP-1	NULL
and	NULL
NFAT	NULL
sites	NULL
present	NULL
in	NULL
pGM4T7	NULL
(	NULL
pGMA4T7CBEF-E	NULL
)	NULL
.	NULL

We	NULL
again	NULL
observed	NULL
a	NULL
doubling	NULL
of	NULL
the	NULL
inducible	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
GM450	NULL
CBF	NULL
motif	NULL
is	NULL
also	NULL
a	NULL
functional	NULL
transcription	NULL
activation	NULL
element	NULL
.	NULL

Discussion	NULL
The	NULL
activity	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
appears	NULL
to	NULL
be	NULL
governed	NULL
by	NULL
a	NULL
cluster	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Sp1	NULL
sites	NULL
in	NULL
the	NULL
distal	NULL
region	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
and	NULL
closely	NULL
associated	NULL
CBF	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NFATp/c	NULL
sites	NULL
in	NULL
the	NULL
proximal	NULL
region	NULL
.	NULL

The	NULL
proximal	NULL
region	NULL
of	NULL
the	NULL
promoter	NULL
was	NULL
found	NULL
in	NULL
this	NULL
study	NULL
to	NULL
be	NULL
able	NULL
to	NULL
support	NULL
one-third	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
full-length	NULL
promoter	NULL
,	NULL
and	NULL
its	NULL
inducible	NULL
activity	NULL
was	NULL
highly	NULL
dependent	NULL
upon	NULL
an	NULL
intact	NULL
CBF	NULL
binding	NULL
site	NULL
.	NULL

At	NULL
least	NULL
three	NULL
previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
CBF	NULL
region	NULL
is	NULL
required	NULL
for	NULL
promoter	NULL
function	NULL
(	NULL
14-16	NULL
)	NULL
,	NULL
but	NULL
these	NULL
studies	NULL
did	NULL
not	NULL
identify	NULL
CBF	NULL
as	NULL
a	NULL
factor	NULL
binding	NULL
in	NULL
this	NULL
region	NULL
.	NULL

A	NULL
preliminary	NULL
report	NULL
from	NULL
the	NULL
laboratory	NULL
of	NULL
Dr.	NULL
S.	NULL
Nimer	NULL
does	NULL
,	NULL
however	NULL
,	NULL
also	NULL
indicate	NULL
that	NULL
CBF	NULL
is	NULL
an	NULL
important	NULL
regulator	NULL
of	NULL
the	NULL
human	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
CBF	NULL
site	NULL
is	NULL
highly	NULL
conserved	NULL
because	NULL
the	NULL
TGTGGTCA	NULL
motif	NULL
exists	NULL
in	NULL
both	NULL
the	NULL
mouse	NULL
and	NULL
human	NULL
GM-CSF	NULL
promoters	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
a	NULL
recent	NULL
report	NULL
has	NULL
found	NULL
that	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
is	NULL
also	NULL
regulated	NULL
by	NULL
CBF	NULL
-like	NULL
factors	NULL
(	NULL
26	NULL
)	NULL
.	NULL

It	NULL
is	NULL
unclear	NULL
,	NULL
however	NULL
,	NULL
why	NULL
we	NULL
have	NULL
not	NULL
detected	NULL
YY-1	NULL
binding	NULL
to	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
,	NULL
as	NULL
has	NULL
been	NULL
reported	NULL
by	NULL
others	NULL
(	NULL
15	NULL
)	NULL
.	NULL

These	NULL
differences	NULL
may	NULL
relate	NULL
to	NULL
binding	NULL
conditions	NULL
,	NULL
the	NULL
cells	NULL
used	NULL
,	NULL
or	NULL
the	NULL
different	NULL
choices	NULL
of	NULL
probes	NULL
used	NULL
for	NULL
DNA	NULL
binding	NULL
.	NULL

Because	NULL
there	NULL
is	NULL
some	NULL
evidence	NULL
that	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
is	NULL
repressed	NULL
by	NULL
YY-1	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
CBF	NULL
and	NULL
YY-1	NULL
represent	NULL
an	NULL
activator	NULL
and	NULL
a	NULL
repressor	NULL
competing	NULL
for	NULL
occupancy	NULL
of	NULL
the	NULL
same	NULL
site	NULL
.	NULL

Because	NULL
the	NULL
proposed	NULL
YY-1	NULL
site	NULL
also	NULL
overlaps	NULL
the	NULL
adjacent	NULL
AP-1	NULL
site	NULL
(	NULL
15	NULL
)	NULL
,	NULL
the	NULL
balance	NULL
may	NULL
be	NULL
tipped	NULL
in	NULL
favor	NULL
of	NULL
CBF	NULL
binding	NULL
upon	NULL
induction	NULL
of	NULL
AP-1	NULL
via	NULL
the	NULL
TCR	NULL
pathway	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
a	NULL
previous	NULL
report	NULL
(	NULL
16	NULL
)	NULL
,	NULL
we	NULL
have	NULL
found	NULL
no	NULL
evidence	NULL
for	NULL
the	NULL
existence	NULL
of	NULL
an	NULL
inhibitory	NULL
element	NULL
upstream	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
CBF	NULL
sites	NULL
in	NULL
the	NULL
promoter	NULL
and	NULL
enhancer	NULL
exist	NULL
in	NULL
a	NULL
similar	NULL
context	NULL
.	NULL

Both	NULL
reside	NULL
within	NULL
regions	NULL
defined	NULL
as	NULL
the	NULL
minimum	NULL
essential	NULL
core	NULL
required	NULL
for	NULL
significant	NULL
inducible	NULL
activity	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
these	NULL
core	NULL
regions	NULL
comprise	NULL
single	NULL
closely	NULL
linked	NULL
binding	NULL
sites	NULL
for	NULL
CBF	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NFATp/c	NULL
.	NULL

We	NULL
suggest	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
these	NULL
three	NULL
sites	NULL
cooperate	NULL
as	NULL
a	NULL
functional	NULL
unit	NULL
in	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
and	NULL
enhancer	NULL
.	NULL

There	NULL
is	NULL
also	NULL
some	NULL
evidence	NULL
to	NULL
suggest	NULL
that	NULL
these	NULL
factors	NULL
may	NULL
synergize	NULL
via	NULL
distinct	NULL
mechanisms	NULL
.	NULL

We	NULL
have	NULL
found	NULL
NFAT	NULL
sites	NULL
to	NULL
be	NULL
closely	NULL
associated	NULL
with	NULL
DNasel	NULL
hypersensitive	NULL
sites	NULL
(	NULL
10	NULL
)	NULL
,	NULL
and	NULL
our	NULL
preliminary	NULL
evidence	NULL
suggests	NULL
that	NULL
NFATp/c	NULL
proteins	NULL
can	NULL
function	NULL
as	NULL
chromatin	NULL
modifying	NULL
fac-tors	NULL
.	NULL
``	NULL

CBF	NULL
may	NULL
also	NULL
have	NULL
a	NULL
distinct	NULL
role	NULL
because	NULL
it	NULL
appears	NULL
to	NULL
be	NULL
tightly	NULL
associated	NULL
with	NULL
structures	NULL
within	NULL
nuclei	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Our	NULL
own	NULL
preliminary	NULL
immunochistochemistry	NULL
using	NULL
CBFa	NULL
antisera	NULL
with	NULL
Jurkat	NULL
cells	NULL
revealed	NULL
a	NULL
speckled	NULL
staining	NULL
pattern	NULL
reminiscent	NULL
of	NULL
transcriptionally	NULL
active	NULL
domains	NULL
within	NULL
the	NULL
nuclear	NULL
matrix.©	NULL
Taken	NULL
together	NULL
,	NULL
these	NULL
observations	NULL
may	NULL
suggest	NULL
a	NULL
function	NULL
for	NULL
CBF	NULL
as	NULL
an	NULL
intranuclear	NULL
homing	NULL
signal	NULL
that	NULL
allows	NULL
other	NULL
adjacent	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
to	NULL
dock	NULL
with	NULL
the	NULL
transcription	NULL
apparatus	NULL
within	NULL
transcriptionally	NULL
active	NULL
nuclear	NULL
domains	NULL
.	NULL

GM-CSF	NULL
is	NULL
expressed	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
,	NULL
and	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
CBF	NULL
regulates	NULL
GM-CSF	NULL
promoter	NULL
function	NULL
in	NULL
myeloid	NULL
cells	NULL
and	NULL
endothelial	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Previous	NULL
studies	NULL
in	NULL
endothelial	NULL
cells	NULL
found	NULL
the	NULL
CBF-binding	NULL
region	NULL
to	NULL
be	NULL
required	NULL
for	NULL
efficient	NULL
GM-CSF	NULL
promoter	NULL
activation	NULL
(	NULL
14	NULL
)	NULL
.	NULL

®	NULL
P.	NULL
Cockerill	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

©	NULL
G.	NULL
Cockerill	NULL
and	NULL
P.	NULL
Cockerill	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

CBF	NULL
could	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
autocrine	NULL
expression	NULL
of	NULL
GM-CSF	NULL
in	NULL
the	NULL
subset	NULL
of	NULL
AMLs	NULL
that	NULL
rely	NULL
on	NULL
GM-CSF	NULL
for	NULL
their	NULL
growth	NULL
.	NULL

Paradoxically	NULL
,	NULL
however	NULL
,	NULL
AMLT	NULL
gene	NULL
translocations	NULL
lead	NULL
to	NULL
expression	NULL
of	NULL
a	NULL
dominant	NULL
repressor	NULL
form	NULL
of	NULL
CBF	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

This	NULL
raises	NULL
the	NULL
intriguing	NULL
possibility	NULL
that	NULL
there	NULL
exists	NULL
another	NULL
subset	NULL
of	NULL
AMLs	NULL
that	NULL
avoid	NULL
programmed	NULL
differentiation	NULL
by	NULL
suppressing	NULL
expression	NULL
of	NULL
differentiation	NULL
factors	NULL
such	NULL
as	NULL
GM-CSF	NULL
,	NULL
or	NULL
their	NULL
receptors	NULL
.	NULL

There	NULL
are	NULL
two	NULL
lines	NULL
of	NULL
evidence	NULL
that	NULL
would	NULL
support	NULL
such	NULL
a	NULL
hypothesis	NULL
:	NULL
(	NULL
a	NULL
)	NULL
there	NULL
do	NULL
exist	NULL
AML	NULL
s	NULL
that	NULL
can	NULL
be	NULL
extinguished	NULL
in	NULL
vivo	NULL
by	NULL
administration	NULL
of	NULL
GM-CSF	NULL
(	NULL
5	NULL
)	NULL
,	NULL
and	NULL
GM-CSF	NULL
induces	NULL
differentiation	NULL
and	NULL
clonal	NULL
extinction	NULL
of	NULL
human	NULL
HL6O	NULL
leukemic	NULL
cells	NULL
in	NULL
culture	NULL
(	NULL
4	NULL
)	NULL
;	NULL
and	NULL
(	NULL
b	NULL
)	NULL
there	NULL
is	NULL
evidence	NULL
that	NULL
GM-CSF	NULL
can	NULL
act	NULL
as	NULL
an	NULL
autocrine	NULL
differentiation	NULL
factor	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
CBF	NULL
has	NULL
the	NULL
potential	NULL
to	NULL
influence	NULL
the	NULL
growth	NULL
and	NULL
differentiation	NULL
of	NULL
myeloid	NULL
cells	NULL
by	NULL
either	NULL
activating	NULL
or	NULL
repressing	NULL
GM-CSF	NULL
expression	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Plasmid	NULL
.	NULL

Luciferase	NULL
reporter	NULL
gene	NULL
plasmids	NULL
were	NULL
constructed	NULL
by	NULL
inserting	NULL
human	NULL
GM-CSF	NULL
promoter	NULL
fragments	NULL
within	NULL
the	NULL
multiple	NULL
cloning	NULL
sites	NULL
of	NULL
pGL3-Basic	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Promoter	NULL
fragments	NULL
originated	NULL
from	NULL
either	NULL
oligonucleotides	NULL
or	NULL
pGMIluc	NULL
(	NULL
12	NULL
)	NULL
,	NULL
and	NULL
their	NULL
sequences	NULL
were	NULL
verified	NULL
as	NULL
being	NULL
the	NULL
same	NULL
as	NULL
the	NULL
reported	NULL
human	NULL
GM-CSF	NULL
sequence	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

14	NULL
shows	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
proximal	NULL
promoter	NULL
and	NULL
the	NULL
5	NULL
untranslated	NULL
region	NULL
that	NULL
is	NULL
common	NULL
to	NULL
all	NULL
of	NULL
the	NULL
plasmids	NULL
created	NULL
in	NULL
this	NULL
study	NULL
.	NULL

pGM627	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
a	NULL
HindIII	NULL
fragment	NULL
of	NULL
pGMluc	NULL
into	NULL
the	NULL
HindIII	NULL
site	NULL
of	NULL
pGL3-Basic	NULL
and	NULL
contains	NULL
the	NULL
full-length	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
-627	NULL
to	NULL
+28	NULL
)	NULL
.	NULL

pGMS55	NULL
has	NULL
the	NULL
proximal	NULL
promoter	NULL
sequence	NULL
truncated	NULL
at	NULL
-55	NULL
and	NULL
was	NULL
constructed	NULL
by	NULL
deleting	NULL
the	NULL
BstEll	NULL
fragment	NULL
of	NULL
pGM627	NULL
that	NULL
encompasses	NULL
the	NULL
-627	NULL
to	NULL
-56	NULL
segment	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

pGM47	NULL
,	NULL
pGM69	NULL
,	NULL
pGM6IACBF	NULL
,	NULL
and	NULL
pGM47CBF-E	NULL
were	NULL
constructed	NULL
by	NULL
deleting	NULL
a	NULL
Sacl	NULL
fragment	NULL
(	NULL
-627	NULL
to	NULL
-21	NULL
)	NULL
from	NULL
pGM627	NULL
and	NULL
inserting	NULL
the	NULL
oligonucleotides	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

18	NULL
in	NULL
its	NULL
place	NULL
.	NULL

pGM627ACBF	NULL
was	NULL
constructed	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
Hindll	NULL
!	NULL

fragment	NULL
of	NULL
pGMIluc	NULL
in	NULL
the	NULL
plasmid	NULL
pAlter	NULL
and	NULL
using	NULL
an	NULL
Altered	NULL
Sites	NULL
II	NULL
kit	NULL
,	NULL
according	NULL
to	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Promega	NULL
)	NULL
with	NULL
the	NULL
CBF	NULL
mutant	NULL
site	NULL
oligonucleotide	NULL
CCCT-GGCATTTTGTCCTCACCATTAATC	NULL
.	NULL

Gel	NULL
Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assays	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
assayed	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
4	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
were	NULL
incubated	NULL
with	NULL
0.2	NULL
ng	NULL
of	NULL
probe	NULL
DNA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dl-dC	NULL
)	NULL
and	NULL
100	NULL
ng	NULL
boiled	NULL
sonicated	NULL
herring	NULL
DNA	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
25	NULL
ng	NULL
of	NULL
oligonucleotide	NULL
duplex	NULL
competitor	NULL
or	NULL
3	NULL
ul	NULL
of	NULL
antisera	NULL
was	NULL
included	NULL
during	NULL
the	NULL
incubation	NULL
.	NULL

CBFa	NULL
and	NULL
CBFB	NULL
antisera	NULL
were	NULL
obtained	NULL
from	NULL
N.	NULL
Speck	NULL
(	NULL
Dartmouth	NULL
Medical	NULL
School	NULL
,	NULL
Hanover	NULL
,	NULL
NH	NULL
;	NULL
Ref	NULL
.	NULL

18	NULL
)	NULL
.	NULL

The	NULL
unrelated	NULL
control	NULL
rabbit	NULL
antisera	NULL
was	NULL
raised	NULL
against	NULL
the	NULL
GM-CSF	NULL
receptor	NULL
.	NULL

Transfections	NULL
and	NULL
Luciferase	NULL
Assays	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
g	NULL
CsCi-purified	NULL
plasmid	NULL
DNA	NULL
by	NULL
electroporation	NULL
,	NULL
stimulated	NULL
with	NULL
20	NULL
ng/ml	NULL
PMA	NULL
,	NULL
and	NULL
1	NULL
um	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Acknowledgments	NULL
We	NULL
are	NULL
indebted	NULL
to	NULL
N.	NULL
Speck	NULL
for	NULL
providing	NULL
CBF	NULL
antisera	NULL
and	NULL
L.	NULL
Coles	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

We	NULL
thank	NULL
Jo	NULL
Burrows	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Gasson	NULL
,	NULL
J.	NULL
C.	NULL
Molecular	NULL
physiology	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

Blood	NULL
,	NULL
77	NULL
;	NULL
1131-1145	NULL
,	NULL
1991	NULL
.	NULL

2	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Naito	NULL
,	NULL
Y.	NULL
T.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
N.	NULL
Expression	NULL
of	NULL
lym-phokine	NULL
genes	NULL
.	NULL

immunologist	NULL
,	NULL
7	NULL
:	NULL
198-203	NULL
,	NULL
1993	NULL
.	NULL

3	NULL
.	NULL

Russel	NULL
,	NULL
N.	NULL
H.	NULL
Autocrine	NULL
growth	NULL
factors	NULL
and	NULL
leukemic	NULL
haemopoiesis	NULL
.	NULL

Blood	NULL
Rev	NULL
.	NULL

,	NULL
6	NULL
:	NULL
149-156	NULL
,	NULL
1992	NULL
.	NULL

4	NULL
.	NULL

Begley	NULL
,	NULL
G.	NULL
,	NULL
Metcalf	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Nicola	NULL
,	NULL
N.	NULL
A.	NULL
Purified	NULL
colony	NULL
stimulating	NULL
factors	NULL
(	NULL
G-CSF	NULL
and	NULL
GM-CSF	NULL
)	NULL
induce	NULL
differentiation	NULL
in	NULL
human	NULL
HL6O	NULL
leu-	NULL
921	NULL
Regulation	NULL
of	NULL
the	NULL
GM-CSF	NULL
Gene	NULL
by	NULL
CBF	NULL
kemic	NULL
cells	NULL
with	NULL
suppression	NULL
of	NULL
clonogenicity	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
39	NULL
:	NULL
99-105	NULL
,	NULL
1987	NULL
.	NULL

5	NULL
.	NULL

Bassan	NULL
,	NULL
R.	NULL
,	NULL
Rambaldi	NULL
,	NULL
A.	NULL
,	NULL
Amaru	NULL
,	NULL
R.	NULL
,	NULL
Motta	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Barbui	NULL
,	NULL
T.	NULL
Unexpected	NULL
remission	NULL
of	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
after	NULL
GM-CSF	NULL
.	NULL

Br	NULL
.	NULL

J	NULL
.	NULL

Haema-tol	NULL
.	NULL

,	NULL
87	NULL
:	NULL
835-838	NULL
,	NULL
1994	NULL
.	NULL

6	NULL
.	NULL

Jenkins	NULL
,	NULL
F.	NULL
,	NULL
Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
Bohmann	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Shannon	NULL
,	NULL
M.	NULL
F.	NULL
Multiple	NULL
signals	NULL
are	NULL
required	NULL
for	NULL
function	NULL
of	NULL
the	NULL
human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
155	NULL
:	NULL
1240-1251	NULL
,	NULL
1995	NULL
.	NULL

7	NULL
.	NULL

Tsuboi	NULL
,	NULL
A.	NULL
,	NULL
Muramatsu	NULL
,	NULL
M.	NULL
,	NULL
Tsutsumi	NULL
,	NULL
A.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
N.	NULL
Cal-cineurin	NULL
activates	NULL
transcription	NULL
from	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
synergy	NULL
with	NULL
either	NULL
protein	NULL
kinase	NULL
C	NULL
or	NULL
NF-KB/AP-1	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

,	NULL
199	NULL
;	NULL
1064-1072	NULL
,	NULL
1994	NULL
.	NULL

8	NULL
.	NULL

Nimer	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Morita	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Martis	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Wachsman	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Gasson	NULL
,	NULL
J.	NULL
C.	NULL
Characterization	NULL
of	NULL
the	NULL
human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
region	NULL
by	NULL
genetic	NULL
analysis	NULL
:	NULL
correlation	NULL
with	NULL
DNase	NULL
!	NULL

footprinting	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
:	NULL
1979-1984	NULL
,	NULL
1988	NULL
.	NULL

9	NULL
.	NULL

Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
Shannon	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Bert	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Ryan	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Vadas	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

The	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor/interleukin	NULL
3	NULL
locus	NULL
is	NULL
regulated	NULL
by	NULL
an	NULL
inducible	NULL
cyclosporin	NULL
A-sensitive	NULL
enhancer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
:	NULL
2466-2470	NULL
,	NULL
1993	NULL
.	NULL

10	NULL
.	NULL

Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
Bert	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Jenkins	NULL
,	NULL
F.	NULL
,	NULL
Ryan	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Shannon	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
and	NULL
Vadas	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

Human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
enhancer	NULL
function	NULL
is	NULL
associated	NULL
with	NULL
cooperative	NULL
interactions	NULL
between	NULL
AP-1	NULL
and	NULL
NFATp/c	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
:	NULL
2071-2079	NULL
,	NULL
1995	NULL
.	NULL

11	NULL
.	NULL

Osbome	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
Vadas	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
mouse	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor/	NULL
IL-3	NULL
locus	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
155	NULL
;	NULL
226-235	NULL
,	NULL
1995	NULL
.	NULL

12	NULL
.	NULL

Himes	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Coles	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
Katsikeros	NULL
,	NULL
R.	NULL
,	NULL
Lang	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
and	NULL
Shannon	NULL
,	NULL
M.	NULL
F.	NULL
HTLV-1	NULL
tax	NULL
activation	NULL
of	NULL
the	NULL
GM-CSF	NULL
and	NULL
G-CSF	NULL
promoters	NULL
requires	NULL
the	NULL
interaction	NULL
of	NULL
NF-kB	NULL
with	NULL
other	NULL
transcription	NULL
factor	NULL
families	NULL
.	NULL

Oncogene	NULL
,	NULL
8	NULL
:	NULL
3189-3197	NULL
,	NULL
1993	NULL
.	NULL

13	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Yamaguchi-lwai	NULL
,	NULL
Y.	NULL
,	NULL
Tsuboi	NULL
,	NULL
A.	NULL
,	NULL
Hung	NULL
,	NULL
P.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
N.	NULL
The	NULL
transcription	NULL
factor	NULL
Sp1	NULL
is	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
murine	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

,	NULL
205	NULL
:	NULL
1518-1525	NULL
,	NULL
1994	NULL
.	NULL

14	NULL
.	NULL

Kaushansky	NULL
,	NULL
K.	NULL
Control	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
production	NULL
in	NULL
normal	NULL
endothelial	NULL
cells	NULL
by	NULL
positive	NULL
and	NULL
negative	NULL
regulatory	NULL
elements	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
143	NULL
:	NULL
2525-2529	NULL
,	NULL
1989	NULL
.	NULL

15	NULL
.	NULL

Jianping	NULL
,	NULL
Y.	NULL
,	NULL
Young	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
Ortaldo	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Ghosh	NULL
,	NULL
P.	NULL
Identification	NULL
of	NULL
a	NULL
DNA	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
nuclear	NULL
factor	NULL
YY1	NULL
in	NULL
the	NULL
human	NULL
GM-CSF	NULL
core	NULL
promoter	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
22	NULL
:	NULL
5672-5678	NULL
,	NULL
1994	NULL
.	NULL

16	NULL
.	NULL

Nimer	NULL
,	NULL
S.	NULL
,	NULL
Fraser	NULL
,	NULL
J.	NULL
,	NULL
Richards	NULL
,	NULL
J.	NULL
,	NULL
Lynch	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Gasson	NULL
,	NULL
J	NULL
.	NULL

The	NULL
repeated	NULL
sequence	NULL
CATT	NULL
(	NULL
A/T	NULL
)	NULL
is	NULL
required	NULL
for	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
activity	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
10	NULL
:	NULL
6084-6088	NULL
,	NULL
1990	NULL
.	NULL

17	NULL
.	NULL

Redondo	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Pfohl	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Hernandez-Munain	NULL
,	NULL
C.	NULL
,	NULL
Wang	NULL
,	NULL
S.	NULL
,	NULL
Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Krangel	NULL
,	NULL
M.	NULL
S.	NULL
Indistinguishable	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
functional	NULL
core	NULL
sites	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
&	NULL
and	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancers	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
;	NULL
4817-4823	NULL
,	NULL
1992	NULL
.	NULL

18	NULL
.	NULL

Cameron	NULL
,	NULL
S.	NULL
,	NULL
Taylor	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
TePas	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Mathey-Prevot	NULL
,	NULL
B	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
critical	NULL
regulatory	NULL
site	NULL
in	NULL
the	NULL
human	NULL
interleu-kin-3	NULL
promoter	NULL
by	NULL
in	NULL
vivo	NULL
footprinting	NULL
.	NULL

Blood	NULL
,	NULL
83	NULL
:	NULL
2851-2859	NULL
,	NULL
1994	NULL
.	NULL

19	NULL
.	NULL

Zhang	NULL
,	NULL
D.	NULL
,	NULL
Fujioka	NULL
,	NULL
K.	NULL
,	NULL
Hetherington	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Shapiro	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
Chen	NULL
,	NULL
H.	NULL
,	NULL
Look	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
Identification	NULL
of	NULL
a	NULL
region	NULL
which	NULL
directs	NULL
the	NULL
monocytic	NULL
activity	NULL
of	NULL
the	NULL
colony-stimulating	NULL
factor	NULL
1	NULL
(	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
)	NULL
receptor	NULL
promoter	NULL
and	NULL
binds	NULL
PEBP2/CBF	NULL
(	NULL
AML1	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
:	NULL
8085-8095	NULL
,	NULL
1994	NULL
.	NULL

20	NULL
.	NULL

Tanaka	NULL
,	NULL
T.	NULL
,	NULL
Tanaka	NULL
,	NULL
K.	NULL
,	NULL
Ogawa	NULL
,	NULL
S.	NULL
,	NULL
Kurokawa	NULL
,	NULL
M.	NULL
,	NULL
Mitani	NULL
,	NULL
K.	NULL
,	NULL
Nishida	NULL
,	NULL
J.	NULL
,	NULL
Shibata	NULL
,	NULL
Y.	NULL
,	NULL
Yazaki	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Hirai	NULL
,	NULL
H.	NULL
An	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
gene	NULL
,	NULL
AML1	NULL
,	NULL
regulates	NULL
myeloid	NULL
cell	NULL
differentiation	NULL
and	NULL
transcriptional	NULL
activation	NULL
antagonistically	NULL
by	NULL
two	NULL
alternatively	NULL
spliced	NULL
forms	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
14	NULL
:	NULL
341-350	NULL
,	NULL
1995	NULL
.	NULL

21	NULL
.	NULL

Meyers	NULL
,	NULL
S.	NULL
,	NULL
Lenny	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
The	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
fusion	NULL
protein	NULL
interferes	NULL
with	NULL
AML-1B-dependent	NULL
transcriptional	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
:	NULL
1974-1982	NULL
,	NULL
1995	NULL
.	NULL

22	NULL
.	NULL

Liu	NULL
,	NULL
P.	NULL
,	NULL
Tarle	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Hajra	NULL
,	NULL
A.	NULL
,	NULL
Claxton	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Marlton	NULL
,	NULL
P.	NULL
,	NULL
Freedman	NULL
,	NULL
M.	NULL
,	NULL
Sicifiano	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Collins	NULL
,	NULL
F.	NULL
S.	NULL
Fusion	NULL
between	NULL
transcription	NULL
factor	NULL
and	NULL
a	NULL
myosin	NULL
heavy	NULL
chain	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
2617	NULL
:	NULL
1041-1044	NULL
,	NULL
1993	NULL
.	NULL

23	NULL
.	NULL

Kaushansky	NULL
,	NULL
K.	NULL
,	NULL
O'Hara	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Berkner	NULL
,	NULL
K.	NULL
,	NULL
Segal	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Hagen	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
and	NULL
Adamson	NULL
,	NULL
J.	NULL
W.	NULL
Genomic	NULL
cloning	NULL
,	NULL
characterization	NULL
,	NULL
and	NULL
multilineage	NULL
growth-promoting	NULL
activity	NULL
of	NULL
human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
83	NULL
:	NULL
3101-3105	NULL
,	NULL
1986	NULL
.	NULL

24	NULL
.	NULL

Golemis	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Hopkins	NULL
,	NULL
N.	NULL
Alignment	NULL
of	NULL
U3	NULL
region	NULL
sequences	NULL
of	NULL
mammalian	NULL
type	NULL
C	NULL
viruses	NULL
:	NULL
identification	NULL
of	NULL
highly	NULL
conserved	NULL
motifs	NULL
and	NULL
implications	NULL
for	NULL
enhancer	NULL
design	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
64	NULL
:	NULL
534-542	NULL
,	NULL
1990	NULL
.	NULL

25	NULL
.	NULL

Nimer	NULL
,	NULL
S.	NULL
,	NULL
Uchida	NULL
,	NULL
H.	NULL
,	NULL
Zhang	NULL
,	NULL
J.	NULL
,	NULL
Hiebert	NULL
,	NULL
S.	NULL
,	NULL
Meyers	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Frank	NULL
,	NULL
R.	NULL
AML1/ETO	NULL
can	NULL
block	NULL
transactivation	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
by	NULL
AML1B	NULL
.	NULL

9th	NULL
Symposium	NULL
on	NULL
the	NULL
Molecular	NULL
Biology	NULL
of	NULL
Hematopoiesis	NULL
.	NULL

Acta	NULL
Haematol	NULL
.	NULL

93	NULL
:	NULL
168	NULL
,	NULL
1995	NULL
.	NULL

26	NULL
.	NULL

Takahashi	NULL
,	NULL
A.	NULL
,	NULL
Satake	NULL
,	NULL
M.	NULL
,	NULL
Yamaguchi-lwai	NULL
,	NULL
Y.	NULL
,	NULL
Bae	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Lu	NULL
,	NULL
J.	NULL
,	NULL
Maruyama	NULL
,	NULL
M.	NULL
,	NULL
Zhang	NULL
,	NULL
Y.	NULL
W.	NULL
,	NULL
Oka	NULL
,	NULL
H.	NULL
,	NULL
Arai	NULL
,	NULL
N.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Ito	NULL
,	NULL
Y	NULL
.	NULL

Positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
activity	NULL
by	NULL
AML1-related	NULL
transcription	NULL
factor	NULL
,	NULL
PEPB2	NULL
.	NULL

Blood	NULL
,	NULL
86	NULL
:	NULL
607-616	NULL
,	NULL
1995	NULL
.	NULL

27	NULL
.	NULL

Heusohn	NULL
,	NULL
F.	NULL
,	NULL
Pohler	NULL
,	NULL
U.	NULL
,	NULL
Decker	NULL
,	NULL
T.	NULL
,	NULL
Just	NULL
,	NULL
U.	NULL
,	NULL
Ostertag	NULL
,	NULL
W.	NULL
,	NULL
Lohmann-Matthes	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Baccarini	NULL
,	NULL
M.	NULL
Coordinate	NULL
expression	NULL
of	NULL
the	NULL
lineage-specific	NULL
growth	NULL
factor	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
CSF	NULL
)	NULL
-1	NULL
and	NULL
its	NULL
receptor	NULL
selectively	NULL
promotes	NULL
macrophage	NULL
maturation	NULL
during	NULL
differentiation	NULL
of	NULL
multipotential	NULL
progenitor	NULL
cells	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

,	NULL
5	NULL
:	NULL
1119-1126	NULL
,	NULL
1994	NULL
.	NULL

